|A recording of the webinar is now available for On-Demand viewing.|
|This project is funded in part by Texas Health & Human Services Texas Targeted Opioid Response.|
CME: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine and UT College of Pharmacy. The Joe R. & Teresa Lozano Long San Antonio School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Long School of Medicine designates this material for a maximum of 1.0 AMA PRA Category 1 Credit™ .
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.1 CEUs (1.00 contact hour) of continuing education credit. In order to receive 1.00 contact hour of CE credit, the participant must watch the webinar / video in its entirety, complete the online post-test, and complete online evaluation.
The Mobile Methadone: Policy Implications and Notes from the Field webinar will describe laws and regulations pertinent to the creation of new mobile methadone programs in the U.S.. and the impact of existing mobile methadone programs on access and outcomes. Programs faculty will consider and discuss potential implementation models and ethical issues related to mobile methadone programs in Texas.
Corey S. Davis, JD, MSPH, EMT
Director, Harm Reduction Legal Project, Network for Public Health Law
Deputy Director, Southeastern Region, Network for Public Health Law
Corey’s work focuses on public health, particularly on identifying and leveraging legal and policy initiatives to reduce drug-related harm. He provides expertise and assistance to a wide spectrum of individuals and organizations working to reduce that harm, from federal officials to volunteer-run syringe access programs. He has served as chair of the Orange County, NC board of health and co-chair of the board of the North Carolina Public Health Foundation. He has authored dozens of peer-reviewed articles and holds faculty appointments at the Brody School of Medicine and Occidental College.
Disclosure: Corey Davis has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.
Sean S. Soth
Director of Health Integration and Innovation
Evergreen Treatment Services
Sean Soth, rhymes with both, has been working in Substance Use Disorder Treatment for 12-years with experience in inpatient, intensive outpatient, co-occurring, and MOUD. Sean received a bachelors in Sociology and Ethnic Studies from Central Washington University and went on to complete studies to obtain his counseling credential. As a teenager Sean's mother was a communicable health nurse amid the AIDS epidemic in a small rural town in central Washington. The experience of seeing individuals marginalized and stigmatized left an enduring mark on Sean's life and cleared a path to his work today. Sean has been with Evergreen Treatment Services for 6-years and in his role as Director of Health Integration and Innovation is focused on providing access to high quality, low barrier treatment services. In his tenure with ETS Sean has led the development and implementation of case management services, peer services, and community-based rapid-access to MOUD all with a continued focus on compliance and quality improvement.
Disclosure: Sean Soth has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.
Director of Strategic Initiatives, Evergreen Treatment Services
Catherine Perez has been with ETS for over 5 years. She started out as a clinic manager and has been working in healthcare management for the past 15 years. Catherine enjoys building relationships with communities and educating on what ETS does and how these services are very much needed.
Disclosure: Catherine Perez has no relevant financial relationship(s) with commercial interests or conflicts of interest to disclose.